Showing results (171-180 of 1,177) with videos related to
Sort By:
Pageof 118
Applied Health Economics and Health Policy|June 30, 2009
Health-promoting schools: evidence for a holistic approach to promoting health and improving health literacyAlbert LeeApplied Health Economics and Health Policy|November 4, 2010
The missing technology: an international comparison of human capital investment in healthcareBianca K FrognerApplied Health Economics and Health Policy|November 4, 2010
The use of research abstracts in formulary decision making by the Joint Oncology Drug Review of CanadaAdam V Weizman, Josh Griesman, Chaim M BellApplied Health Economics and Health Policy|November 2, 2010
Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methodsJulie Ratcliffe, Leah Couzner, Terry Flynn, et al.Applied Health Economics and Health Policy|April 4, 2013
Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literatureMairead Skally, Paul Hanly, Linda SharpApplied Health Economics and Health Policy|March 16, 2013
Is it financially efficient to lose the ring-fenced elective orthopaedic ward?J Agustin Soler, Sanjiv Manjure, Yegappan KalairajahApplied Health Economics and Health Policy|October 10, 2013
Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: implications for other countriesUlrik Hesse, Brian Godman, Max Petzold, et al.Applied Health Economics and Health Policy|August 9, 2014
Cost utility of telaprevir-PR (peginterferon-ribavirin) versus boceprevir-PR and versus PR alone in chronic hepatitis C in The NetherlandsAikaterini Vellopoulou, Michel van Agthoven, Annemarie van der Kolk, et al.Applied Health Economics and Health Policy|May 18, 2012
Cost-effectiveness analysis of treatments for vertebral compression fracturesAvram A Edidin, Kevin L Ong, Edmund Lau, et al.Applied Health Economics and Health Policy|July 17, 2013
Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in IrelandDawn Lee, Patrick Thornton, Alexander Hirst, et al.Pageof 118